Newsbenzinga
This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod
· Published
Article summary
Major FDA wins for AstraZeneca: Truqap combination approved for advanced prostate cancer; Ultomiris kidney disease drug gets Priority Review.
An excerpt from the original article.
Comments —
Loading comments…